Highly bioavailable curcumin from CAVACURMIN® empowers your formulation with unique advantages: 40 times better absorption than pure curcumin products and easy formulation into shots, capsules and tablets. Read the clinical human study on the exceptional bioavailability of CAVACURMIN® – published by the European Journal of Nutrition.
Wacker Chemie AG
Tel. +49 89 6279-1346
Fax. +49 89 6279-2507
Amino Acids,Chemicals - Encapsulated,Emulsifiers and Emulsifier Systems,Fibers,Nutraceutical and Functional Food Ingredients,Starch and Starch Products
Wacker Biosolutions, Wacker’s life science and biotechnology division, offers a broad range of innovative tailored products and solutions for the life science sector –, particularly for the functional food and nutraceutical industries.
These include Cavamax® W6 alpha-cyclodextrin, a natural, starch-derived oligosaccharide. It can be added as a fully fermentable dietary fiber to foods and beverages, including carbonated and non-carbonated transparent soft drinks. Cavamax® W6 is scientifically proven to significantly reduce the post-prandial glycaemic response – an effect officially acknowledged by EFSA. Besides, it interacts with triglycerides building up a surfactant-like structure that stabilizes oil-in-water emulsions efficiently. With Cavamax® W6, Wacker thus offers manufacturers a possibility to replace emulsifiers with a soluble fiber.
Furthermore, Wacker offers molecular encapsulation solutions based on our cyclodextrin technology for odor or taste-masking, to stabilize food ingredients against heat and oxidation and to increase the bioavailability of functional ingredients. We have over 15 years of experience in manufacturing and formulating alpha-, beta- and gamma-cyclodextrins.
Additionally, Wacker produces a high-quality range of non-human, non-animal derived L-cysteine products. Wacker is the world’s only manufacturer of vegetarian-grade cysteine using a patented biotech process.
28 Feb 2018 --- Cholesterol’s deadly relationship with heart disease is well known around the world today. Cardiovascular disease continues to be one of the world’s most urgent health problems – for example, heart failure affects about 6.5 million adults over age 20 in the US, according to the American Heart Association.
27 Sep 2017 --- Wacker has announced the results of a human clinical study demonstrating that their hydroxytyrosol HTEssence is capable of significantly reducing low-density lipoprotein (LDL) cholesterol. At SupplySide West 2017 (September 27-29, Las Vegas), the company is exhibiting its “nature-identical” hydroxytyrosol HTEssence.
12 May 2017 --- One of the standout trends at Vitafoods 2017 was the rise of products featuring turmeric and its derivative, curcumin. “The market for turmeric is blooming,” Alexis Manfre, Nutrition and Health Category Manager at Naturex, tells NutritionInsight. “Turmeric has become the botanical superstar [globally]. If you look at the European market, the recent growth in the last year is 30 to 40%.”